Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA's Pazdur Jumps Over To New 'Moonshot' Role

Executive Summary

Richard Pazdur has been tapped to run the FDA's new Oncology Center of Excellence, which is being created under the White House's National Cancer Moonshot initiative. That means Pazdur, who has been at the FDA since 1999, will be setting aside his duties, for the time being, running the Office of Hematology and Oncology Products – leaving that job in the interim to someone else.

Advertisement

Related Content

Can 'Moon Shot' Lift FDA Out Of Its Silos?
FDA 'Moon Shot' Center To Expedite Combo Cancer Drugs
'Moon Shot' Confusion? NIH Chief Provides Clarity
Obama/Biden: Science Ready For Cancer 'Moon Shot'
FDA Pazdur's Opdivo Love Affair And Other Adventures

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC065540

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel